{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:47:31Z","timestamp":1787032051999,"version":"build-2736575974"},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.5551\/jat.rv22038","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:52Z","timestamp":1749060472000},"page":"1071-1078","source":"Crossref","is-referenced-by-count":8,"title":["ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis"],"prefix":"10.5551","volume":"32","author":[{"given":"Hirotaka","family":"Fukami","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Oike","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Department of Aging and Geriatric Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A and Yanai H: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjaerg-Hansen A and European Atherosclerosis Society Consensus P: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a","DOI":"10.1093\/eurheartj\/eht273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jarcho JA and Keaney JF, Jr.: Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT. N Engl J Med, 2015; 372: 2448-2450","DOI":"10.1056\/NEJMe1507041"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Abifadel M and Boileau C: Genetic and molecular architecture of familial hypercholesterolemia. J Intern Med, 2023; 293: 144-165","DOI":"10.1111\/joim.13577"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M and Komachi Y: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol, 2001; 153: 490-499","DOI":"10.1093\/aje\/153.5.490"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ and Shepherd J: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis, 1994; 106: 241-253","DOI":"10.1016\/0021-9150(94)90129-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Oike Y, Yasunaga K and Suda T: Angiopoietin-related\/angiopoietin-like proteins regulate angiogenesis. Int J Hematol, 2004; 80: 21-28","DOI":"10.1532\/IJH97.04034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H and Furukawa H: Angptl3 regulates lipid metabolism in mice. Nat Genet, 2002; 30: 151-157","DOI":"10.1038\/ng814"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, Ueda K, Inaba T, Minekura H, Kohama T and Furukawa H: ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem, 2002; 277: 33742-33748","DOI":"10.1074\/jbc.M203215200"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Adam RC, Mintah IJ, Alexa-Braun CA, Shihanian LM, Lee JS, Banerjee P, Hamon SC, Kim HI, Cohen JC, Hobbs HH, Van Hout C, Gromada J, Murphy AJ, Yancopoulos GD, Sleeman MW and Gusarova V: Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance. J Lipid Res, 2020; 61: 1271-1286","DOI":"10.1194\/jlr.RA120000888"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Reeskamp LF, Millar JS, Wu L, Jansen H, van Harskamp D, Schierbeek H, Gipe DA, Rader DJ, Dallinga-Thie GM, Hovingh GK and Cuchel M: ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report. Arterioscler Thromb Vasc Biol, 2021; 41: 1753-1759","DOI":"10.1161\/ATVBAHA.120.315204"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, Garimella KV, Fisher S, Abreu J, Barry AJ, Fennell T, Banks E, Ambrogio L, Cibulskis K, Kernytsky A, Gonzalez E, Rudzicz N, Engert JC, DePristo MA, Daly MJ, Cohen JC, Hobbs HH, Altshuler D, Schonfeld G, Gabriel SB, Yue P and Kathiresan S: Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med, 2010; 363: 2220-2227","DOI":"10.1056\/NEJMoa1002926"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Dewey FE, Gusarova V, Dunbar RL, O\u2019Dushlaine C, Schurmann C, Gottesman O, McCarthy S, Van Hout CV, Bruse S, Dansky HM, Leader JB, Murray MF, Ritchie MD, Kirchner HL, Habegger L, Lopez A, Penn J, Zhao A, Shao W, Stahl N, Murphy AJ, Hamon S, Bouzelmat A, Zhang R, Shumel B, Pordy R, Gipe D, Herman GA, Sheu WHH, Lee IT, Liang KW, Guo X, Rotter JI, Chen YI, Kraus WE, Shah SH, Damrauer S, Small A, Rader DJ, Wulff AB, Nordestgaard BG, Tybjaerg-Hansen A, van den Hoek AM, Princen HMG, Ledbetter DH, Carey DJ, Overton JD, Reid JG, Sasiela WJ, Banerjee P, Shuldiner AR, Borecki IB, Teslovich TM, Yancopoulos GD, Mellis SJ, Gromada J and Baras A: Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. N Engl J Med, 2017; 377: 211-221","DOI":"10.1056\/NEJMoa1612790"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tada H, Kojima N, Kawashiri MA and Takamura M: The first Japanese case with familial combined hypolipidemia without any complications caused by loss-of function variants in ANGPTL3: Case report. Heliyon, 2024; 10: e29924","DOI":"10.1016\/j.heliyon.2024.e29924"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D and Investigators EH: Evinacumab for Homozygous Familial Hypercholesterolemia. N Engl J Med, 2020; 383: 711-720","DOI":"10.1056\/NEJMoa2004215"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Watts GF, Schwabe C, Scott R, Gladding PA, Sullivan D, Baker J, Clifton P, Hamilton J, Given B, Melquist S, Zhou R, Chang T, San Martin J, Gaudet D, Goldberg IJ, Knowles JW, Hegele RA and Ballantyne CM: RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. Nat Med, 2023; 29: 2216-2223","DOI":"10.1038\/s41591-023-02494-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, Nicholls SJ, Lucas KJ, San Martin J, Zhou R, Muhsin M, Chang T, Hellawell J, Watts GF and Team A-T: Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med, 2024; 391: 913-925","DOI":"10.1056\/NEJMoa2404147"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ray KK, Oru E, Rosenson RS, Jones J, Ma X, Walgren J, Haupt A, Verma S, Gaudet D, Nicholls SJ and Ruotolo G: Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet, 2025;","DOI":"10.1016\/S0140-6736(25)00507-0"},{"key":"19","unstructured":"19) Bergmark BA, Marston NA, Bramson CR, Curto M, Ramos V, Jevne A, Kuder JF, Park JG, Murphy SA, Verma S, Wojakowski W, Terra SG, Sabatine MS, Wiviott SD and Investigators T-T: Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70. Circulation, 2022; 145: 1377-1386"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Pang Z, Nakagami H, Osako MK, Koriyama H, Nakagami F, Tomioka H, Shimamura M, Kurinami H, Takami Y, Morishita R and Rakugi H: Therapeutic vaccine against DPP4 improves glucose metabolism in mice. Proc Natl Acad Sci U S A, 2014; 111: E1256-1263","DOI":"10.1073\/pnas.1322009111"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kurashiki T, Miyake T, Nakagami H, Nishimura M and Morishita R: Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model. Hypertension, 2020; 76: 1879-1888","DOI":"10.1161\/HYPERTENSIONAHA.119.14442"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kawakami R, Nozato Y, Nakagami H, Ikeda Y, Shimamura M, Yoshida S, Sun J, Kawano T, Takami Y, Noma T, Rakugi H, Minamino T and Morishita R: Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin\/kexin type 9 (PCSK9) epitope in mice. PLoS One, 2018; 13: e0191895","DOI":"10.1371\/journal.pone.0191895"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nakamaru R, Nakagami H, Rakugi H and Morishita R: Future Directions of Therapeutic Vaccines for Chronic Diseases. Circ J, 2020; 84: 1895-1902","DOI":"10.1253\/circj.CJ-20-0703"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fukami H, Morinaga J, Nakagami H, Hayashi H, Okadome Y, Matsunaga E, Kadomatsu T, Horiguchi H, Sato M, Sugizaki T, Kuwabara T, Miyata K, Mukoyama M, Morishita R and Oike Y: Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia. Cell Rep Med, 2021; 2: 100446","DOI":"10.1016\/j.xcrm.2021.100446"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Fukami H, Morinaga J, Nakagami H, Hayashi H, Okadome Y, Matsunaga E, Kadomatsu T, Horiguchi H, Sato M, Sugizaki T, Miyata K, Torigoe D, Mukoyama M, Morishita R and Oike Y: Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine. NPJ Vaccines, 2023; 8: 168","DOI":"10.1038\/s41541-023-00770-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Camenisch G, Pisabarro MT, Sherman D, Kowalski J, Nagel M, Hass P, Xie MH, Gurney A, Bodary S, Liang XH, Clark K, Beresini M, Ferrara N and Gerber HP: ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem, 2002; 277: 17281-17290","DOI":"10.1074\/jbc.M109768200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Lupo MG and Ferri N: Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects. J Cardiovasc Dev Dis, 2018; 5:","DOI":"10.3390\/jcdd5030039"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Morinaga J, Zhao J, Endo M, Kadomatsu T, Miyata K, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M and Oike Y: Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study. PLoS One, 2018; 13: e0193731","DOI":"10.1371\/journal.pone.0193731"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kersten S: Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol, 2017; 13: 731-739","DOI":"10.1038\/nrendo.2017.119"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Morinaga J, Kashiwabara K, Torigoe D, Okadome Y, Aizawa K, Uemura K, Kurashima A, Matsunaga E, Fukami H, Horiguchi H, Sato M, Sugizaki T, Miyata K, Kadomatsu T, Mukoyama M, Miyauchi K, Hokimoto S, Fukumoto Y, Hiro T, Hibi K, Nakagawa Y, Sakuma I, Ozaki Y, Iwata H, Iimuro S, Daida H, Shimokawa H, Kimura T, Matsuzaki M, Saito Y, Matsuyama Y, Nagai R and Oike Y: Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy. Arterioscler Thromb Vasc Biol, 2023; 43: 1549-1559","DOI":"10.1161\/ATVBAHA.122.318880"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Balasubramaniam D, Schroeder O, Russell AM, Fitchett JR, Austin AK, Beyer TP, Chen YQ, Day JW, Ehsani M, Heng AR, Zhen EY, Davies J, Glaesner W, Jones BE, Siegel RW, Qian YW and Konrad RJ: An anti-ANGPTL3\/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. J Lipid Res, 2022; 63: 100198","DOI":"10.1016\/j.jlr.2022.100198"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/9\/32_RV22038\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:34:07Z","timestamp":1757129647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/9\/32_RV22038\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22038","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"RV22038"}}